EMA recommends Pfizer-BioNTech’s Covid-19 vaccine for children
The EC will review the CHMP's guidance and decide whether to update the vaccine's conditional marketing authorisation.
Biomanufacturers are facing persistent malware attacks, says cybersecurity group
The cyberattack, named Tardigrade, has been identified at two different biomanufacturing facilities.
Digitising the pharma supply chain
The Covid-19 pandemic has highlighted the need for security and traceability at every step of the drug supply chain.
Vaccibody rebrands to Nykode and bags $925m deal with Regeneron
Norwegian vaccine and immunotherapy-focused biopharma Vaccibody has rebranded to Nykode after signing a nearly $1bn deal.
Astellas, Bayer and Mithra likely to turn up the heat in hot flashes market
Late-stage approaches to treat menopause-related hot flashes are expected to hit the market and may offer safer alternatives
Latest Deals
-
AztiqMergers & Acquisitions $475M
-
Twist BioscienceMergers & Acquisitions $190M
-
GSKLicensing Agreement $1BN
-
Novo NordiskMergers & Acquisitions $3.3BN
-
AztiqMergers & Acquisitions $475M
-
Twist BioscienceMergers & Acquisitions $190M
-
GSKLicensing Agreement $1BN
-
Novo NordiskMergers & Acquisitions $3.3BN
Weekly chart
Top countries for AI jobs growth in pharmaceutical in the three months to September
Source: GlobalData
| Country | July-Sept YoY AI jobs growth (%) |
|---|---|
| United States | 4.2 |
| China | 2.1 |
| Poland | 1.9 |
| France | 1.3 |
| India | 0.6 |
| Germany | 0.4 |
Latest News
Aztiq-Innobic consortium to buy Alvogen subsidiary for $475m
Aztiq founder Róbert Wessman will remain in position as Lotus and Adalvo's board chairman.
Clover Biopharmaceuticals begins Covid-19 vaccine booster trial
The trial will analyse the safety and immunogenicity of the booster shot by enrolling healthy adults at several Brazilian sites.
Novavax seeks interim authorisation for Covid-19 vaccine in Singapore
The company’s filing includes positive clinical data from two Phase III trials.
GreenLight and Samsung Biologics to produce Covid-19 vaccines
Samsung will use GreenLight’s manufacturing process to produce the vaccines.
Latest Themes
BYJU’s, India’s most valuable unicorn, is giving the UK an education in AI technology
Byju’s expansion comes to the UK with an innovation hub exploring AI technology in education.
Filings buzz in pharmaceuticals: 25% increase in robotics mentions since Q2 2020
The frequency of sentences related to robotics between July 2020 and June 2021 was 50% higher than in 2016.
Digital media hiring levels in the pharmaceutical industry dropped in October 2021
40% of the companies included in our analysis recruited for at least one digital media position.
Paxlovid: what we know about Pfizer’s Covid-19 pill
Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid.
Cold Wars in the AI Summer: Automation is heating up cyber defence
AI can help forces in the defence of their systems – and offense upon others. But how far ahead are Russia and China?
Robotics-related deals in the pharmaceutical industry increased in H1 2021
Robotics-related deals made up 0.6% of all deals announced in the pharma sector in H1 2021.
Handling consent across different data channels in healthcare
Dealing with consent throughout multiple data channels within healthcare is a complex issue that can even delay treatment for patients. Organisations seeking consent also need to be fully aware of restrictions and regulations in data management. Syrenis CEO Glenn Jackson explains more about the issue of consent in healthcare and how Cassie, the company’s consent and preference management platform, can help.
Amazon Care lands largest customer yet in hotel chain Hilton
Amazon Care, the ecommerce giant’s healthcare business, has signed a deal with Hilton to provide its staff with on-demand virtual medical services.
Expert Commentary & Analysis
View MoreChinese infectious disease venture financing receives a booster from Covid-19
The impact of the Covid-19 pandemic has raised the importance of funding drug development for...
Biogen strengthens its foothold in MS with the approval of Vumerity in Europe
Vumerity is an orally administered, second-generation fumarate that rapidly converts to monomethyl fumarate in the...
Worklessness – not high unemployment a permanent challenge for UK – leading macroeconomic influencers
UK’s reasons for unemployment differ from past recessions.
Supply chain bottlenecks clearing – leading macroeconomic influencers
Supply chain issues are showing signs of easing as Asian output bounces back.